Search
Enter a search term.

File a claim

Need to file an insurance claim? We’ll make the process as supportive, simple and swift as possible.

Action Teams

If you want to make an impact in your community but aren't sure where to begin, we're here to help.

Contact support

Can’t find what you’re looking for? Need to discuss a complex question? Let us know—we’re happy to help.
Use the search bar above to find information throughout our website. Or choose a topic you want to learn more about.

AIM ImmunoTech Inc. Common Stock (NY:AIM)

1.310 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Jan 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 21
Open 1.310
Bid (Size) 1.260 (800)
Ask (Size) 1.320 (1,600)
Prev. Close 1.310
Today's Range 1.310 - 1.310
52wk Range 1.070 - 24.00
Shares Outstanding 2,853,114
Dividend Yield N/A

Top News

More News

Performance

More News

Read More

Frequently Asked Questions

Is AIM ImmunoTech Inc. Common Stock publicly traded?
Yes, AIM ImmunoTech Inc. Common Stock is publicly traded.
What exchange does AIM ImmunoTech Inc. Common Stock trade on?
AIM ImmunoTech Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for AIM ImmunoTech Inc. Common Stock?
The ticker symbol for AIM ImmunoTech Inc. Common Stock is AIM on the New York Stock Exchange
What is the current price of AIM ImmunoTech Inc. Common Stock?
The current price of AIM ImmunoTech Inc. Common Stock is 1.310
When was AIM ImmunoTech Inc. Common Stock last traded?
The last trade of AIM ImmunoTech Inc. Common Stock was at 01/14/26 08:00 PM ET
What is the market capitalization of AIM ImmunoTech Inc. Common Stock?
The market capitalization of AIM ImmunoTech Inc. Common Stock is 3.74M
How many shares of AIM ImmunoTech Inc. Common Stock are outstanding?
AIM ImmunoTech Inc. Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.